ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
PP&E Net
ESSA Pharma Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
PP&E Net
$363.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
PP&E Net
$37.5m
|
CAGR 3-Years
29%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
PP&E Net
$7.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
PP&E Net
$23.9m
|
CAGR 3-Years
129%
|
CAGR 5-Years
85%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
PP&E Net
$112m
|
CAGR 3-Years
120%
|
CAGR 5-Years
209%
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
PP&E Net
CA$850k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
4%
|
See Also
What is ESSA Pharma Inc's PP&E Net?
PP&E Net
363.2k
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's PP&E Net amounts to 363.2k USD.
What is ESSA Pharma Inc's PP&E Net growth rate?
PP&E Net CAGR 1Y
82%
Over the last year, the PP&E Net growth was 82%.